Pancreatic β-cells arise from bipotent trunk progenitors (TrPCs) that are specified from multipotent pancreatic progenitors (MPCs) in a Notch-dependent manner. The time window during which Notch signaling is required to specify TrPCs and the identity of the Notch ligands required for this patterning process remain obscure. Here we show that blocking Notch signal transduction before E13 drives progenitors to an acinar fate while blockade after E13 results in amplified and accelerated endocrine differentiation. Mapping of Dll1 and Jag1 expression using IF and novel targeted reporters revealed that uniform Jag1 expression in E10. 
Introduction
The signaling milieu in the pancreatic progenitor niche is highly dynamic such that a given cue can exert disparate, even opposing effects at distinct stages and in different cell populations contingent upon cellular context. As an exemplar, the Notch signaling pathway not only inhibits but also promotes differentiation of insulin + b-cells during different stages of the pancreatic program.
Defining temporal window(s) of Notch-dependent processes in b-cell formation as well as the source of Notch ligands is important to understand the b-cell differentiation program and inform the rational design of in vitro b-cell differentiation protocols.
The mammalian pancreas arises as dorsal and ventral evaginations of the posterior foregut endoderm, becoming discernible in the mouse at around embryonic day (E)8.75-9.0 (Wessells and Cohen, 1967) , lagging several hours behind pancreatic fate specification evidenced by onset of Pdx1 expression (Offield et al., 1996; Ohlsson et al., 1993) . From outgrowth on, until around E12 when the paired buds are rapidly expanding and branching, the pancreatic epithelium largely comprises multipotent pancreatic progenitor cells (MPCs), distinguished by their expression of several transcription factors including Pdx1, Ptf1a, Hnf1b, Sox9 and Nkx6.1. MPCs give rise to both the exocrine pancreas -the digestive enzyme-producing acinar cells and the ductal cells which transport them to the intestine -and the endocrine islet cells, of which insulin + b-cells comprise the majority (Gu et al., 2002; Kopinke et al., 2011; Kopp et al., 2011; Pan et al., 2013; Solar et al., 2009; Zhou et al., 2007) . Endocrine differentiation proceeds through a transient endocrine precursor expressing high levels of the transcription factor Neurogenin3 (Ngn3), which is both necessary and sufficient for endocrine differentiation (Apelqvist et al., 1999; Gradwohl et al., 2000; Grapin-Botton et al., 2001 ). By E12.5 the paired buds fuse and a ductal tubular plexus is established. Over the next week a synchronous extension and reorganization of the tubular plexus remodels this domain into a unified ductal tree (Kesavan et al., 2009; Villasenor et al., 2010) . Concurrent with this remodeling of the epithelium, the process of proximodistal (PD) patterning which occurs between ~E10.5 to ~E14.5 resolves Ptf1a + Nkx6.1 + MPCs into two developmentally and spatially segregated populations: distally-localized unipotent Ptf1a + Nkx6.1 -"tip" progenitors (TiPCs) committed to an acinar fate and proximal Ptf1a -Nkx6.1 + "trunk" progenitors (TrPCs) which are endocrine-/ductbipotent: TrPCs attaining an Ngn3 Hi state initiate an endocrine program and delaminate from the polarized epithelium with those progenitors failing to do so remaining in situ and adopting a ductal 4 fate (Hald et al., 2008; Schaffer et al., 2010; Zhou et al., 2007) . Genetic mouse models have revealed PD patterning to be driven by a cross-repressive antagonistic loop between Ptf1a and Nkx6.1/Nkx6.2 (Nkx6) with forced Ptf1a expression promoting TiPC commitment while forced Nkx6 expression supports adoption of TrPC fate (Schaffer et al., 2010) . A role for Notch signaling in this process was first implicated by the finding that clonal analysis of cells with forced expression of Notch1 intracellular domain (N1ICD) showed them to segregate to an Nkx6.1 + fate (Schaffer et al., 2010) .
Notch receptors are activated at the plasma membrane by DSL (Delta, Serrate, Lag-2) transmembrane ligands expressed by adjacent cells, comprising members of the Delta-like (Dll) and Jagged families in mammals, initiating ADAM-then γ-secretase-mediated cleavage events, which liberate the Notch intracellular domain (NICD), allowing it to translocate to the nucleus. There, NICD functions as a transcriptional activator by binding to Rbp-jk and recruiting the cofactor Mastermindlike (Maml) and, replacing co-repressors with co-activators to activate the transcription of Notch downstream targets, most notably Hes1 (Bray, 2016) . In the context of pancreas morphogenesis, Notch signaling and Hes1 are required for maintaining the proliferation and undifferentiated status of MPCs by preventing precocious and excessive endocrine differentiation (Ahnfelt-Rønne et al., 2012; Apelqvist et al., 1999; Jensen et al., 2000) . More recently, it was discovered that active Notch signaling is required to commit MPCs to the duct/endocrine-competent TrPC fate: in addition to forced N1ICD expression being shown to promote TrPC commitment (Schaffer et al., 2010) , additional genetic mouse models of Notch signaling blockade (forced expression of dominantnegative -dn -Maml1 or conditional deletion of Mib1 or Hes1) resulted in a gain of TiPCs at the expense of a loss of the TrPC population (Afelik et al., 2012; Horn et al., 2012) . This TrPC-promoting effect of Notch signaling has been speculated to be achieved via direct upregulation of Nkx6.1 expression since Rbpj binds the Nkx6.1 promoter during PD patterning (Afelik et al., 2012) . Once specified, Notch signaling and Hes1 expression persist in TrPCs where they serve to maintain Sox9 expression and ductal fate, and to inhibit endocrine differentiation by repressing Ngn3 (Bankaitis et al., 2015; Klinck et al., 2011; Kopinke et al., 2011; Magenheim et al., 2011; Shih et al., 2012) .
Collectively, these studies show that Notch signaling is required iteratively during the pancreatic program, first to maintain MPCs, then to actively allocate them to a duct/endocrine-competent TrPC fate and subsequently to maintain ductal identify by repressing an endocrine program. However, a number of questions remain unresolved. Foremost amongst these are: 1) what is the temporal 5 window through which Notch signaling is required to allocate MPCs to a TrPC fate, 2) which cells are signal-sending (so, ligand-expressing) and -receiving cells during PD patterning and beyond, and 3) which ligands are expressed during the various stages of pancreas morphogenesis and which are involved in regulating various cell fate decisions? In mice, the DSL ligand family, comprises Jag1, Jag2, Dll1, and Dll4, while the atypical Delta-type ligand Dll3 is thought to act as an intracellular inhibitor of Notch signaling Geffers et al., 2007; Ladi et al., 2005) . Which of the four trans-activating Notch ligands that orchestrate receptor activation at different stages and in different cell fate decisions during pancreatic development remains ill-defined. This is in part a consequence of the lack of validation of commercially-available antibodies and the perdurance of transcriptionally-uncoupled reporters in existing ligand reporter lines. This inability to accurately report real-time expression of Notch ligands is especially problematic given the inherently dynamic nature of Notch signaling (Shimojo and Kageyama, 2016) .
In the present study, we elected to focus upon interrogating the role of Notch signaling in 
Results and Discussion

Notch Signaling Transduction is Required to Allocate MPCs to a TrPC Fate
In order to define the temporal window through which active Notch signaling is required to commit MPCs in the early pancreas to the TrPC fate, the ability to receive and/or transduce Notch signals was abrogated in TrPC-biased MPCs and their progeny. This was achieved via stable and heritable expression of a Rosa26 (R26) locus-targeted dnMaml1-eGFP fusion protein (Horn et al., 2012) in TrPC-fated progenitors and their descendants using TrPC-specific Hnf1b-CreER T2 (Solar et al., 2009) during PD patterning. The R26 dnMaml1-eGFP fusion protein has been shown to be a potent and specific inhibitor of all four mammalian Notch receptors in vivo (High et al., 2008; High et al., 2007; Maillard et al., 2008; Maillard et al., 2004; Tu et al., 2005) . Notch reception was abrogated in TrPC-fated progenitors from E12, conjectured to fall during the window of active PD patterning on the basis of:
1) co-expression of Nkx6.1 and Ptf1a in MPCs largely resolving into distinct trunk and tip domains respectively between E10.5 and E14.5 (Schaffer et al., 2010) also indelibly and heritably labels such "Notch-deaf" cells and their descendants with eGFP, allowing their cell fate within the pancreas to be assessed (Fig. 1A) . Double-heterozygous embryos carrying
Hnf1b-CreER T2 and the R26 YFP Cre reporter allele (Srinivas et al., 2001 ) with tamoxifen administered in an identical manner served as controls, allowing Hnf1b-CreER T2 -recombined Notch signalingintact cells to be YFP-labeled for lineage-tracing (Fig. 1B) . This approach enables relative tissue contributions of Notch-deaf and control Notch-intact TrPCs and their progeny to be directly compared by controlling for differing mitotic indices of the various cell types given that dnMaml1 expression has previously been shown not to affect proliferation rates of pancreatic progenitors (Afelik et al., 2012) . Relative tissue contributions of lineage-labeled cells were assessed at the midpoint of the secondary transition (E15.5) by co-immunofluorescence (IF) analysis on serial sections for GFP (antisera detect both eGFP and YFP). We used two different combinations of lineage markers, either: 1) Ptf1a (TiPC-derived acini) and Sox9 (TrPC-derived endocrine/duct-competent bipotent progenitors) or 2) Sox9, Ngn3 (endocrine precursors) and chromogranin-A (endocrine cells) (Fig. 1D) (Solar et al., 2009) . As CreER undergoes translocation to the nucleus ~6-12 hours post tamoxifen-injection and remains there for approximately 36 hours following administration (Ahn and Joyner, 2004; Danielian et al., 1998) , these findings show that at the population level, Hnf1b + cells are multipotent through the E12-E13 pulse-labeling window resulting from an E11.5 tamoxifen injection (Fig. 1C) .
In stark contrast to control pancreata, when examined at E15.5 following E11. (Fig. 1F,G,I,J) ). This is concordant with blockade of Notch signaling preventing MPCs from committing to a TrPC fate, re-allocating TrPC-destined progenitors to the alternative Notch-independent TiPC lineage (Afelik et al., 2012; Horn et al., 2012) . In addition to the acinar lineage, Notch-abrogated progenitors also contributed to the endocrine lineage with a similar propensity as Notch-intact progenitors in control pancreata: 22.2% of dnMaml1-eGFP + cells coexpressed either chromogranin-A or Ngn3, using antibody combination 2, while 26.5% were Sox9 − Ptf1a − using antibody combination 1 (Fig. 1E-J) . Thus, dnMaml1-mediated inhibition of Notch reception does not induce precocious endocrine differentiation, consistent with previous work (Afelik et al., 2012 (Wang et al., 2010) .
The Window of Notch-Dependent TrPC Allocation Closes by E13
Having confirmed that active Notch signaling is required to allocate MPCs to a TrPC fate at E12-E13, we sought to define the temporal window through which TrPC commitment is Notch-dependent.
To this end, cellular contributions of Notch-deaf versus Notch-intact TrPCs and their progeny were assessed in E15. (Solar et al., 2009 ).
In contrast to control pancreata, in E15.5 Hnf1b-CreER T2 ; R26 dnMaml1-eGFP pancreata, significantly fewer dnMaml1-eGFP + cells co-expressed Sox9 following tamoxifen injection at either E12.5 or E13.5 although Sox9 + dnMaml1 + cells were more abundant following the later injection (E12.5 tamoxifen injection: 4.0%-7.3%; E13.5 injection: 10.4%-24.9%)( Fig. 1K-V) . This resembles the exclusion of Notch-deaf cells from the bipotent progenitor pool seen following tamoxifen injection at E11.5. However, in sharp contrast to dnMaml1 + pancreata exposed to tamoxifen at E11.5 in which 66.3% of dnMaml1-eGFP + cells were Ptf1a + (Fig. 1F,G) , following E12.5 or E13.5 injections, only 20.7% (E12.5) or 11.6% (E13.5) of Notch-deaf cells expressed Ptf1a (Fig. 1L,M Alternatively, dnMaml1 may accelerate the final differentiation step of the newly described endocrine-biased, Ngn3
Lo population that appears to be subject to ongoing Notch signaling (Bechard et al., 2016) . Thus, the predominant cell fate of dnMaml1 + cells shifts from being acinar to being endocrine after E11.5 and E12.5 tamoxifen injections, respectively ( and conclusions on the effects of Hnf1β-CreER T2 -mediated dnMaml1-EGFP expression upon lineage allocation were independently confirmed by qualitative lineage-tracing analyses in which dnMaml1-eGFP expression was driven by TrPC-specific Sox9-CreER T2 (Kopp et al., 2011) . These showed the same shift in progenitor competence upon blockade of Notch signal reception as described above (Fig. S1) . Taken together, these findings show that the window through which active Notch signaling is required to commit MPCs to a TrPC fate closes by E13. Fig. 2A,B) . A previous in situ-based survey of Notch pathway components in the developing mouse pancreas revealed that only Notch1 and Notch2 and of the four trans-activating ligands (Jag1, Jag2, Dll1 and Dll4), only Dll1 are expressed in the early (<~E13.5) pancreatic epithelium during PD patterning (Lammert et al., 2000) . More recent immunofluorescence studies further revealed Jag1 expression in E10.5 pancreatic epithelium (Nakano et al., 2015) . Dll1 expression is first detected in scattered pancreatic epithelial cells at around E9.0 then expands to encompass Ngn3 + cells and many MPCs of the E9.5 dorsal pancreas; similar expression is observed in the E10.5 ventral pancreas; between E13.5 and E15.5, Dll1 is expressed in many but not all Ngn3 analyses with the exception that uniform Jag1 expression was detected in the pancreatic epithelium from E10.5 (Nakano et al., 2015) . Besides Dll1 and Jag1, no other Notch ligand has been described to be expressed in the pancreatic parenchyme. While previous studies have been instrumental in informing our current understanding of Notch ligand expression in the developing pancreas, many bear the caveats that they are reliant upon poorly-validated antisera or dependent upon analysis of transcriptionally-uncoupled surrogate reporters with perdurance far exceeding that of the native ligand protein. In order to circumvent these issues, we employed validated antisera and generated and analyzed novel fusion protein reporters which faithfully recapitulate Jag1 and Dll1 expression.
Jag1 and Dll1 Expression is Enriched in TiPCs while Notch Activation is TrPC-Specific
In these novel Jag1 and Dll1 alleles (Jag1 J1VmC and Dll1 D1VmC , Fig. 2A,B) , Venus is fused to the Cterminus of Jag1 or Dll1 followed by a self-splicing T2A peptide and mCherry. Using a sensitive rabbit anti-GFP antibody to detect expression of the Venus fusion proteins, we observed broad, low-level Jag1 expression in E10.5 dorsal pancreas epithelium (MPCs) as well as in the surrounding mesenchyme ( Fig. 2C,E) . Strikingly, by E12.5 prominent Jag1-Venus expression was restricted to distal TiPC cells at the periphery of the epithelium while it was absent from most proximal TrPCs (Fig. 2D) , revealing Jag1 to be enriched on TiPCs during PD patterning. At E15.5, weak Jag1-Venus expression was detected apically in acinar cells and in non-parenchymal cells, including the vasculature, but expression was excluded from proximal endocrine-/duct-bipotent Sox9 + progenitors (Fig. S3A) . By generating embryos carrying Jag1 J1VmC and a BAC-transgenic Hes1-eGFP reporter (Klinck et al., 2011), we assayed for mCherry as a readout of Jag1 and detected (Hes1-)eGFP using a chicken-raised anti-GFP antibody that only detects high levels of GFP/Venus so fails to detect Jag1-Venus. The mCherry reporter is very sensitive, likely due to the long half-life of the cleaved mCherry protein compared to the Venus fusions. Nevertheless, we failed to detect Jag1 expression at E9.5 (Fig. 2F) , but confirmed the broad, low-level expression in E10.5 dorsal MPCs, many of which co-expressed GFP (Fig. 2G) . At E11.5 mCherry expression intensified in the distal-most epithelium and was downregulated in proximal epithelium where many mCherry − GFP + cells were evident (Fig.   2H ). This pattern was reinforced at E12.5 where mCherry expression was largely confined to distal TiPCs (Fig. 2I) . Notably, GFP + cells were often intercalated within clusters of mCherry + cells at E11.5 and E12.5 (Fig. 2H, I ), suggesting that Notch activation in these cells is regulated independently of Jag1 expression. mCherry expression was also detected in E15.5 acinar cells but at much reduced levels ( Fig. S3C) .
To confirm the principal finding from the Jag1 J1VmC expression analysis that Jag1 expression is enriched on TiPCs during Notch-dependent PD patterning, IF was conducted using two independent Jag1 antisera that were validated using Jag1-null (Xue et al., 1999) tissue (Fig. S2A-D¢¢) .
Weak Jag1 expression was first detected in the E10.5 dorsal and ventral pancreas ( Fig. 2J and Fig.   S2A ,A¢¢,C,C¢¢) and by E12.5 during PD patterning when epithelial Jag1 expression was qualitatively higher than at E10.5, it showed a striking restriction to Ptf1a + Nkx6.1 -TiPCs, and was clearly excluded from Ptf1a -Nkx6.1 + TrPCs (Fig. 2Q ,S,V and Fig. S3G-I ). Confirming findings from the Jag1 J1VmC ; Hes1-eGFP double-reporter analysis, IF for Hes1 using an antibody validated on Hes1-null (Ishibashi et al., 1995) tissue (Fig. S2G-H¢¢) revealed nuclear Hes1 expression to be largely restricted to Ptf1a -Nkx6.1 + TrPCs at E12.5 (Fig. 2Q,R,V) indicating Notch signal transduction to be largely TrPC-specific during 13 PD patterning. Hes1 expression was strongest in TrPCs adjacent to apices of converging Jag1 + TiPC membranes (Fig. 2Q) . High Hes1 signal was, however, also evident in a few solitary Ptf1a + Nkx6.1 -TiPCs expressing Jag1, again indicating that Notch activation in these cells is regulated independently of Jag1 expression (Fig. 2Q) . Additionally, Jag1 was excluded from the endocrine lineage at all stages examined (Fig. S3H,K) . Such TiPC-enriched Jag1 expression at E12.5 is discordant with previous reports of uniform pancreatic epithelial Jag1 expression at this stage using anti-Jag1
antisera (Golson et al., 2009a; Nakano et al., 2015) . While we cannot fully explain these discrepancies, we suspect they may be related to the low signal-to-noise ratio for anti-Jag1
antibodies.
In contrast to Jag1-Venus, the Dll1-Venus reporter was detected in scattered cells of the E10.5 dorsal pancreas, many of which were Sox9 Lo/− (Fig. 2J,K) . This pattern was maintained at E12.5
with scattered Dll1-Venus + Sox9
Lo/− cells in proximal and distal epithelium (Fig. 2L) . At E15.5 we detected Dll1-Venus expression apically in acinar cells, and in scattered Sox9 Lo/− proximal epithelial cells (Fig. S3B) . Analogous to the Jag1 J1VmC ; Hes1-eGFP analysis, we generated and examined
Dll1
J1VmC ; Hes1-eGFP embryos and, consistent with our previous results (Ahnfelt-Rønne et al., 2012)
we detected Dll1-mCherry in scattered cells of the E9.5 dorsal pancreas (Fig. 2M) (Fig. 2M) , suggesting the mCherry + cells to be engaged in active signaling. A few cells co-expressed mCherry and GFP, which may be explained by perdurance of mCherry and/or GFP after transcription has ceased. The same pattern was observed at E10.5, E11.5, and E12.5 ( Fig. 2N-P) . At E15.5 many mCherry + cells were found in acini, often interspersed with GFP + cells although the majority of GFP + cells were Sox9 + bipotent progenitors (Fig. S3D-F (Fig. 2R) .
IF for both fusion protein reporters and endogenous ligands permitted an examination of ligand co-expression. Consistent with the results described above, a large overlap was observed between Jag1 and Dll1 expression at E10.5 (Fig. 2E,J) . Some Dll1 + Jag1 − cells were noted and likely represent Ngn3 + cells. Furthermore, a subset of Jag1 + TiPCs at E12.5 was Dll1-mCherry + (Fig. S3E) and this mosaic Dll1 expression in distal epithelium was retained in E15.5 acinar cells (Fig. S3F) . IF for Dll1 and Jag1 at E12.5 during PD patterning confirmed the expression of Dll1 in a subset of Jag1 + TiPCs (Fig. 2S,V) .
Finally, as Notch1 and Notch2 were previously detected in the early (<~E13.5) pancreatic epithelium during PD patterning (Lammert et al., 2000) , we assayed for their expression at E12.5 using commercially-available antisera. While Notch1 was uniformly expressed in Ptf1a + Nkx6.1 -TiPCs and Ptf1a -Nkx6.1 + TrPCs (Fig. 2T) , Notch2 was specifically enriched on TrPCs (Fig. 2U) .
In sum, these expression analysis findings show two sources of Notch ligand at E12.5 during PD patterning: TiPCs specifically present Jag1 to the most distal TrPC (or TrPC-fated) progenitors while Dll1 is expressed heterogeneously on isolated cells (some Ngn3 + endocrine precursors)
throughout the epithelium where it is presented to the most proximal TrPCs. Given their largely exclusive Hes1 expression, Notch signal transduction is predominantly TrPC-specific during PD patterning. As Notch1 is expressed on both TiPCs and TrPCs but Notch2 is enriched on the latter, TiPCs bear a higher ligand:receptor ratio than do TrPCs (Fig. 2V) . Taken together, these results support Notch signal-sending from distal prospective TiPCs and Notch-reception in proximal presumptive TrPCs during PD patterning. (Pan et al., 2013) were unsuccessful owing to the inability to obtain sufficiently high recombination efficiency in contiguous TiPCs to exert an effect on adjacent TrPCs (data not shown).
Distal Notch Signals are Required to Specify Terminal Duct Cells
While early development of Mib1
ΔPtf1a pancreata is ostensibly normal, morphogenesis is perturbed later. Analysis at E15.5 revealed the ductal tree to be laterally truncated such that the most distal Sox9 + TrPCs/duct cells which normally protrude into the nascent Ptf1a + acini of control pancreata ( Fig. 3A-A' ', arrows), are specifically absent in Mib1 ΔPtf1a embryos (Fig. 3B-B'' , asterisks).
The absence of both DAPI + nuclei (Fig. 3B) and YFP-labeled recombined cells (Fig. 3B,B' ) within the acini supports cell loss as opposed to Sox9 downregulation. Ablation of this specific cell population is consistent with the apical concentration of Dll1 and Jag1 on the adjacent Ptf1a + acinar cells in the secondary transition pancreas (Fig. S3F,L,R) . It is also concordant with the notion that Notch signaling and, so, the pancreatic program, are only perturbed when Mib1, and thus signal-sending, is efficiently ablated. This can occur following multiple rounds of Ptf1a
Cre -mediated recombination in TiPCs and their acinar progeny in which Ptf1a
Cre is more robustly expressed compared with MPCs.
Given that the most distal Sox9 + cells in the secondary transition pancreas are widely accepted to be the precursors of the adult terminal duct/centroacinar (CAC) cells (Beer et al., 2016) , this phenotype closely resembles the loss of CAC cells seen following Ptf1a Cre -driven double deletion of Dll1 and Jag1 (Nakano et al., 2015) . Although the distal-most Sox9 + cells are present in E15.5 compound mutants, showing them to be initially specified, reduced survival (decreased proliferation and increased apoptosis) renders them almost undetectable by E18.5 (Nakano et al., 2015) . Together, these results suggest that Notch signaling via ligands expressed on TiPCs and their acinar progeny is required to support adjacent terminal TrPCs/duct cells.
Mosaic Endodermal Deletion of Dll1 and Jag1 Singly or in Combination Perturbs PD Patterning
Given the abundant epithelial expression of Jag1 and Dll1 during PD patterning ( Fig. 2 and Fig. S3 (Fig. S4A-B ',E-G), confirming a role for Dll1 in the proper specification of TrPCs. In contrast, Ptf1a -Nkx6.1 + TrPCs appear to be specified normally in Jag1 ΔSox17Tam embryos.
However, Ptf1a + Nkx6.1 + co-expressing cells were increased in number (P=0.006) at the expense of Ptf1a + Nkx6.1 -TiPCs although the decrease in the latter just failed to reach statistical significance (P=0.077) (Fig. S4A,A',C,C',E-G) . Nevertheless, this result is remarkable as it is inconsistent with Jag1 functioning as a classical Notch activator during PD patterning: loss of TrPC-specifying trans-activating Notch activity would be predicted to reduce the TrPC domain with concomitant TiPC expansion. Rather, the loss of TiPCs suggests that Jag1 is required cell-autonomously to inhibit Notch. As Rbpj directly binds the Nkx6.1 promoter during PD patterning (Afelik et al., 2012) , ectopic Notch activation in TiPCs upon Jag1 ablation might conceivably directly promote TiPC Nkx6.1 expression accounting for the increased Ptf1a + Nkx6.1 + co-positive population observed in the E12.5
Jag1
ΔSox17Tam pancreas.
In relation to single Dll1
ΔSox17Tam and Jag1 ΔSox17Tam mutants, compound Dll1/Jag1
ΔSox17Tam mutants displayed an intermediate phenotype (Fig. S4A-G 
Dll1/Jag1
ΔSox17Tam mutants also exhibited an expansion of the Ptf1a + Nkx6-1 + co-positive population (P=0.001 compared to controls). Thus, while interpretation of these findings is confounded by the mosaic nature of the ligand deletion, these results show that both Jag1 and Dll1 are required for
proper PD patterning by allowing timely resolution of Ptf1a and Nkx6.1 segregation.
Jag1 is Required for Specifying All But the 10% Proximal-Most TrPCs
As described above, after protracted breeding of Foxa2 T2AiCre and Jag1-flox animals, linkage between the two alleles was broken, allowing the generation of Jag1 
Foxa2
T2AiCre/+ control offspring were recovered at the expected 1:1 ratio.
Examination of Jag1
ΔFoxa2 embryos at E10.5 revealed both the dorsal and ventral pancreata to be of normal size and morphology with no evidence of precocious endocrine differentiation (data not shown) despite efficient, near-complete recombination as assessed by R26 YFP (Fig. 4A-B' ). This was mirrored at E12.5 with the Jag1 ΔFoxa2 mutant pancreas appearing grossly normal in both size and morphology. However, IF analysis revealed the Jag1 ΔFoxa2 pancreas to be more poorly branched/lobulated than that of littermate controls (Fig. 4A-B'') . Moreover, the proportion of pancreatic cells expressing Ptf1a (either Nkx6.1 + or -) was significantly increased (P=0.0361) at the expense of a loss of Ptf1a -Nkx6.1 + TrPCs (P=0.0361) (Fig. 4A-C) . While Ptf1a expression at E12.5 typically demarcates only the distal-most epithelial cells (Fig. 4A,A'' ) after gradual downregulation from E10.5 when it marks the majority of the MPCs in the epithelium (Kawaguchi et al., 2002; Schaffer et al., 2010) , Ptf1a continued to be expressed by Jag1 ΔFoxa2 pancreatic cells more proximal to this as well as at qualitatively higher levels than in control pancreata (Fig. 4B,B'') To assess how the loss of Jag1 ligand impacts Notch signaling during PD patterning, we assayed for Hes1 in Jag1 ΔFoxa2 pancreata given inconsistent IF detection of cleaved N1ICD in our hands. This revealed that while Hes1 expression and, so, active Notch transduction, is normally largely confined to TrPCs at E12.5 ( Fig. 2I,P ,Q,R,V and Fig. 4D ), Hes1 IF signal was upregulated in the distal-most epithelial cells of the E12.5 Jag1 ΔFoxa2 pancreas (Fig. 4E,F) . Thus, loss of Jag1 in TiPCs during PD patterning results in increased Notch activity in these cells. This is consistent with the above proposal that Jag1 is required cell-autonomously to inhibit Notch in TiPC cells. It is not implausible to think that without this delineation between Notch Lo distal cells and Notch Hi proximal cells, segregation of MPCs into TiPC and TrPC cells respectively is unable to proceed.
By assaying for Ptf1a and either Nkx6.1 or Sox9 for TrPC/bipotent endocrine-duct-competent progenitors, we determined that resolution into distinct Ptf1a + Nkx6.1 -distal and Ptf1a -Nkx6.1 + proximal domains does not occur until E14.5 in the Jag1 ΔFoxa2 pancreas, two days later than normal (Fig. S5A-D,G-J) . Through this stage, endocrine differentiation, as assessed on the basis of Ngn3 + endocrine precursors and insulin + b-cell numbers, appears ostensibly unaffected (Fig. S5E,F ,K,L) and data not shown). By E15.5 however, delayed PD patterning in the Jag1 ΔFoxa2 pancreas manifests in a striking ~85% decrease (P=0.0003) in Nkx6.1 + cells relative to control littermates ( Fig. 5A-C) despite gross morphology and pancreas size remaining largely unaffected (Fig. 5I-J') . As Nkx6.1 expression defines both endocrine-/duct-bipotent progenitors ("ducts") and b-cells in the secondary transition pancreas, we assayed for Sox9 and insulin respectively to distinguish between these two cell types.
This analysis revealed a dramatic ~90% reduction (P<0.0001) in Sox9 + cells and a two-fold decrease (P=0.0062) in insulin + b-cells in the E15.5 Jag1 ΔFoxa2 mutant versus littermate control pancreas ( Fig.   5D-F) . Both section and wholemount IF analysis revealed only the proximal-most Sox9 + cells to be retained in the mutant pancreas (Fig. 5E,H,J,J' ). This suggests that Jag1 is required for specifying ~90% of TrPCs with the remainder induced Jag1-independently via other ligand(s) most likely expressed in the proximal epithelium. Delayed PD patterning and failure to specify the majority of the TrPC population manifests in severe dysmorphogenesis of the ductal tree: mirroring Sox9, ductal cells marked by Hnf1b and DBA are reduced in the E15.5 Jag1 ΔFoxa2 pancreas, to be found only in the proximal-most epithelium (data not shown). This phenotype resembles a far more severe ductal paucity than that previously shown via mosaic Jag1 deletion in the early pancreas (Golson et al., 2009a; Golson et al., 2009b) . Perhaps most strikingly, despite the severe depletion of the ductal tree, the cytoarchitecture of the acinar and the overall pancreas is largely unaffected in the absence of Jag1. Acinar structure is largely maintained and acinar cells express mature acinar markers including Ptf1a, Mist1, amylase and CPA1 in the E15.5 and E18.5 Jag1 ΔFoxa2 pancreas (Fig. 5B,H ,L, Fig. S7D ). This is despite acini being isolated from Sox9 + duct cells: even when discontinuous ducts occur in E15.5 mutants, they often terminate prematurely and are not "capped" by a Ptf1a + nascent acinus as in control littermates (Fig. 5G,H) . In addition, elongated ductlike structures can be morphologically identified in the proximal epithelium E15.5 Jag1
Fig. S6B,C,E,F,H,I,K,L and
ΔFoxa2 pancreata which express Ptf1a (and Mist1), not Sox9 (Fig. 5H,L) . Concordant with maintenance of acinar architecture despite ductal paucity, apicobasal polarity (as assessed by expression of Muc1, ZO-1 and PKCz) is maintained in the E15.5 Jag1 ΔFoxa2 pancreas (Fig. S6A-F') . By E18.5, just prior to birth (and the latest stage that mutants could be recovered due to neonatal lethality), Jag1
ΔFoxa2 pancreata were still equivalent in size to those of control littermates (Fig. S7) . Endocrine cell depletion was prominent, especially so for later-arising somatostatin + d-cells, consistent with a more pronounced lack of endocrine-/duct-competent bipotent progenitors during later pancreas development (Fig. S7B) . While paucity of the ductal tree, as assessed by IF for Muc1, Cytokeratin 19 (CK19) and DBA, was obvious, "ring"-like structures expressing both acinar (amylase and CPA1) as well as ductal (CK19) markers, were widespread throughout the E18.5 Jag1 ΔFoxa2 pancreatic epithelium (Fig. S6I,I ',L,L' and Fig. S7D,F) . While this is consistent with acinar-to-ductal metaplasia, 20 genetic lineage-tracing approaches to specifically label acinar cells in the Jag1 mutant will be required to test this.
Jag1 and Dll1 Specify Endocrine-/Duct-Competent TrPCs
As mentioned above, while ~90% of TrPCs are lost in the Jag1 ΔFoxa2 mutant, the remaining ~10%
proximal-most TrPCs are specified in a Jag1-independent manner, most likely by a ligand(s) (Fig. 6A,B,E,I ). Both compound Jag1/Dll1 ΔFoxa2 mutants examined mirrored the other in exhibiting a more profound loss of Nkx6.1 + cells (P=0.0014) and increase in Ptf1a + cells (P=0.0056) than either single mutant (Fig. 6F,I ). Almost all Nkx6.1 + cells were ablated from every tissue section, except for those at the site of the main duct. Similar to Nkx6.1 + cells, Sox9 + cell numbers were unchanged between E15.5 Dll1 ΔFoxa2 and control pancreata while they were severely reduced in
Jag1
ΔFoxa2 mutants (P<0.0001) (Fig. 6C,D,G,J) . Again, compound Jag1/Dll1 ΔFoxa2 mutants exhibited a more profound decrease in Sox9 + cells (P=0.0003) than either single mutant (Fig. 6H,J) . Numbers of insulin + b-cells were reduced in both E15.5 Dll1 ΔFoxa2 and Jag1 ΔFoxa2 mutants relative to controls (P=0.0083 and P=0.0003 respectively) while compound Jag1/Dll1 ΔFoxa2 mutants exhibited a more profound loss (P<0.0001) than either single mutant alone (Fig. 6C,D,G,H,K) . Thus, given that the near-complete ablation of TrPC derivatives in embryos lacking both Jag1 and Dll1 phenocopies
Mib1
ΔFoxa2 mice lacking all Notch signal-sending ability (Horn et al., 2012) , it can be argued that the remaining 10% of TrPCs specified in Jag1 ΔFoxa2 embryos are specified by Dll1 cues provided by proximal epithelial cells. It was recently shown that the pancreatic ducts in zebrafish are specified by Jagged1b (Jag1b) and Jagged2b (Jag2b) (Zhang et al., 2017) . Our findings hereby show that their function in mammals is served by Jag1 and Dll1. We show that these ligands are expressed respectively on distal TiPCs and more proximal epithelium during PD patterning in the mouse with Jag1 specifying the majority of the ductal tree (Jag1) and the 10% of proximal-most TrPCs being specified by proximal epithelial Dll1 cues. 
Materials & Methods
Mice
Published mouse strains used herein include: R26 (Solar et al., 2009 ), Sox9-CreER T2 (Kopp et al., 2011 ), Ptf1a Cre (Kawaguchi et al., 2002 and
Ptf1a
CreERTM (Pan et al., 2013) . Transgenic reporters for Dll1 (Dll1 D1VmC ) and Jag1 (Jag1 J1VmC ) were generated in the lab of Ryoichiro Kageyama ( Fig. 2A,B CreERT2 -mediated ligand deletion) body-weight administered by intraperitoneal injection at noon ± 1 hour.
All animal experiments described herein were conducted in accordance with European legislation and authorized by the Danish Regulatory Authority.
Histology and Immunofluorescence Analysis
Dissected whole embryos (E10.5-E12.5) and foregut preparations (E13.5-E18.5) were fixed in 4% paraformaldehyde in PBS, cryoembedded in Tissue-Tek O.C.T. (Sakura Finetek) and sectioned at 10
µm. For immunofluorescence analysis, antigen retrieval was conducted in pH6.0 citrate buffer, followed by permeabilization in 0.15% Triton X-100 in PBS. After blocking in 1% normal donkey serum in PBS with 0.1% Tween-20, sections were incubated overnight at 4°C with primary antibodies (listed in 
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